[BMJ] Aducanumab: European agency rejects Alzheimer’s drug over efficacy and safety concerns

user1 Post time 2021-12-21 21:56:58 | Show all posts |Read mode
Reward10points

journal:BMJ

Authors:Elisabeth Mahase

Published date:--

DOI:10.1136/bmj.n3127

Article link:http://dx.doi.org/10.1136/bmj.n3127

Article Source:BMJ


Remark:

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply2 Show all posts
David Post time 2021-12-21 21:56:59 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

user1 Post time 2021-12-21 22:43:04 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    160

Latest Reply

Return to the list